Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease
Clinical trial NCT00812565 · COMPLETED
Trial details
- NCT number
- NCT00812565
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-09-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.